Amdocs (DOX) is back in focus after reporting quarterly revenue and earnings per share ahead of its own guidance, while rolling out its new agentic operating system, aOS, and securing fresh commercial deals.

Despite the upbeat earnings surprise and fresh GenAI contracts, recent share price momentum has been weak, with the stock down over the past month and year, and multi year total shareholder returns also negative.

If Amdocs' GenAI push has you thinking about where else automation could reshape returns, this is a good moment to scan 40 AI infrastructure stocks

With the stock down over 20% year to date despite ongoing GenAI wins and an indicated discount to some valuation models, you need to ask: is Amdocs quietly undervalued here, or is the market already pricing in future growth?

Most Popular Narrative: 31.3% Undervalued

At a last close of $61.93 against a fair value narrative of $90.21, Amdocs is framed as having meaningful upside potential in this widely followed view.

The accelerating adoption of cloud, automation, and AI/ML across telecom and media sectors is driving a multi-year wave of IT stack modernization, with Amdocs winning new large-scale modernization and migration deals in cloud, generative AI, and data services, this is expanding its total addressable market and supporting sustained topline revenue growth.

Curious what has to happen for that higher fair value to hold up? Revenue, margins, free cash flow and future P/E all need to line up in a very specific way.

Result: Fair Value of $90.21 (UNDERVALUED)

However, this hinges on telcos actually following through on digital spend and on Amdocs scaling cloud and GenAI services fast enough to offset any pressure on margins.

Next Steps

If the mix of GenAI momentum and share price weakness leaves you unsure, take a closer look at the numbers yourself and move quickly to shape your own view. You can start with the 4 key rewards.

Looking for more investment ideas?

Do not stop with one stock. Broaden your watchlist using targeted screeners so you can quickly spot fresh opportunities before they move away from you.

• Target stability first by checking stocks that score well on resilience and risk using the 67 resilient stocks with low risk scores.
• Pinpoint companies that combine strong fundamentals with healthy balance sheets through the solid balance sheet and fundamentals stocks screener (45 results).
• Hunt for lesser known opportunities with quality metrics that stand out by scanning the screener containing 22 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.